恒瑞医药(600276.SH)：SHR7280片上市许可申请获受理

Core Viewpoint - Heng Rui Medicine (600276.SH) has received acceptance for its drug listing application for SHR7280 tablets from the National Medical Products Administration (NMPA) [1] Group 1 - The drug SHR7280 is intended for use in assisted reproductive technology to control ovarian stimulation in patients, specifically to prevent early luteinizing hormone (LH) peaks [1]